This content is machine translated Aortic valve stenosis What is the role of the primary care physician? Various heart specialists from the University Hospital Zurich discussed the diagnosis and treatment of aortic valve stenosis at the Zurich Heart House, Foundation for Cardiovascular Research. The disease, treated purely…
View Post 6 min This content is machine translated Chronic heart failure and stroke prevention in VHF. Optimized treatment regimens and new therapeutic options The December lecture series in Zurich featured a presentation by PD Georg Noll, MD, on the treatment of chronic heart failure, in which he shared his practical clinical experience. The…
View Post 7 min This content is machine translated 4th Bern Heart Valve Symposium New transfemoral TAVI systems and the Swiss TAVI Registry The new transfemoral TAVI systems, either in development or already certified, address potential vulnerabilities and limitations, such as paravalvular insufficiency or risk of vascular complication. This article, based on a…
View Post 4 min This content is machine translated Interview on the ACC/AHA guidelines Lipid treatment recommendation meets with little approval Statins continue to be the drug of choice for LDL-C therapy, although not all patients achieve their target levels with therapy alone. However, the paradigm shift implemented in the new…
View Post 6 min This content is machine translated Anticoagulation in cardiac assist devices No study results with new oral anticoagulants to date. Anticoagulation must be individualized to the support system and patient. Patients with non-pulsatile systems have been shown to have acquired von Willebrand syndrome, which increases the risk for bleeding complications.…
View Post 4 min This content is machine translated Diabetes mellitus Type 2 diabetes – Targeting the inflammation At the advanced training day “Pro and Contra in Endocrinology” in Biel, Prof. Marc Donath, MD, Chief of Endocrinology, Diabetology and Metabolism at the University Hospital Basel, spoke on the…
View Post 9 min This content is machine translated Interventional treatment of mitral valve regurgitation MitraClip, Mitral Annuloplasty and Valve Replacement Interventional treatment of mitral regurgitation has become increasingly important in recent years. Important advances in catheter technology as well as imaging now allow us to treat patients who until recently…
View Post 10 min This content is machine translated Anticoagulation from the perspective of internal medicine Foundations for an individualized “Choosing wisely”. DOAK are at least equal to standard therapy with VKA in non-valvular VCF and venous thromboembolism in terms of safety and efficacy. The intracranial bleeding risk is halved. Consequently, they…
View Post 3 min This content is machine translated Direct oral anticoagulants “Teaching Old Docs New Tricks?” Recently, I was discussing (as an older “doc”) with one of my marcoumar anticoagulated 87-year-old patients with atrial fibrillation, status post anterior myocardial infarction with akinesia, status post severe gastric…
View Post 5 min This content is machine translated 9th Zurich Hypertension Day Relaxed blood pressure targets for high-risk patients The 9th Zurich Hypertension Day focused on the changes to the European Hypertension Guidelines and the treatment of important concomitant or secondary diseases such as atrial fibrillation.
View Post 9 min This content is machine translated New oral anticoagulants 10 questions from daily use The new oral anticoagulants (NOAKs) have long since become part of everyday clinical practice in stroke prophylaxis for atrial fibrillation. Due to their simpler, safer, and effective use, they are…
